Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Forum for Health Economics & Policy

Editor-in-Chief: Goldman, Dana


CiteScore 2017: 0.53

SCImago Journal Rank (SJR) 2017: 0.425
Source Normalized Impact per Paper (SNIP) 2017: 0.297

Online
ISSN
1558-9544
See all formats and pricing
More options …

Evidence of Inefficiencies in Practice Patterns: Regional Variation in Medicare Medical and Drug Spending

Melinda Buntin / Tamara Hayford
  • Corresponding author
  • Congressional Budget Office – HRLD, Ford House Office Building, Washington, District of Columbia 20515, United States of America
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2016-03-04 | DOI: https://doi.org/10.1515/fhep-2015-0034

Abstract

Several studies have explored the causes and magnitude of geographic variation in Medicare spending and service use, but most of these studies have not taken into account that pharmaceuticals may substitute for medical service use. We address this issue using Medicare medical and pharmaceutical administrative claims data to explore the correlation between medical and pharmaceutical spending and utilization; we also examine medical and pharmaceutical use for subsets of the Medicare population with certain chronic conditions often treated with drugs. Beneficiary-level regressions with controls for health status and demographics were used to construct standardized medical spending and pharmaceutical spending and utilization measures for each region and patient cohort. Areas with higher medical spending tend to have higher pharmaceutical spending in general. However, areas with higher medical spending also tend to have lower pharmaceutical spending for conditions for which prescription drugs may substitute for additional medical care. Both of these patterns are consistent with less efficient medical practices in higher-spending areas. Likewise, more expensive drugs and more broad-spectrum antibiotics, which are often considered discretionary and overused, are more likely to be prescribed in higher-spending areas. Our results suggest that care may be provided more efficiently in some regions than in others. However, additional research is needed to investigate relationships between spending and health care outcomes, and what types of policies may create incentives for higher-spending regions to reduce spending without a loss in quality.

Keywords: geographic variation; health economics; medicare; prescription drugs

JEL Classification: I1; I180

References

  • AHRQ (2007) Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension, by David B. Matchar, Douglas C McCrory, Lori A Orlando, Manesh R Patel, Uptal D Patel, Meenal B Patwardhan, Benjamin Powers, Gregory P Samsa, and Rebecca N Gray. Rockville, MD: Agency for Healthcare Research and Quality. Available at: http://www.effectivehealthcare.ahrq.gov/reports/final.cfm.

  • Baicker, Katherine and Amitabh Chandra (2004) “Medicare Spending, The Physician Workforce, and Beneficiaries’ Quality of Care,” Health Affairs. doi: . http://content.healthaffairs.org/content/early/2004/04/07/hlthaff.w4.184.short.Crossref

  • Chandra, Amitabh and Douglas O. Staiger (2007) “Productivity Spillovers in Healthcare: Evidence from the Treatment of Heart Attacks,” Journal of Political Economy, 115:103–140.CrossrefGoogle Scholar

  • Chandra, Amitabh, Jonathan Gruber and Robin McKnight (2010) “Patient Cost-Sharing and Hospitalization Offsets in the Elderly,” American Economic Review, 100(1):193–213.CrossrefWeb of ScienceGoogle Scholar

  • CMS (2009) Geographic Variation in Drug Prices and Spending in the Part D Program. In: (Thomas MaCurdy, Jonathan Gibbs, Nick Theobald, Thomas DeLeire, Tim Kautz, and Margaret O’Brien-Strain, eds.) Baltimore: Centers for Medicare and Medicaid Services. Available at: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics- Trends-and-Reports/Reports/downloads/MaCurdy_RxGeoPrice_RTC_2009.pdf.

  • CMS (2010) Final Report on the Sixth Update of the Geographic Practice Cost Index for the Medicare Physician Fee Schedule. In: (Margaret O’Brien-Strain, West Addison, Nick Theobald, eds.) Centers for Medicare and Medicaid Services. Burlingame, CA: Acumen, LLC. Available at: http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/Downloads/CY-2015-PFS-Proposed-Rule-Revised-Final-Report-on-the-CY-2014-GPCI-Update-for-MPFS_CMS-1612-P.pdf.

  • Congressional Budget Office (2012) Offsetting Effects of Prescription Drug Use on Medicare’s Spending for Medical Services, by Tamara B. Hayford, and Melinda B. Buntin. Washington, DC: CBO. Available at: http://www.cbo.gov/publication/43741.

  • Donohue, Julie M., Nancy E. Morden, Walid F. Gellad, Julie P. Bynum, Weiping Zhou, Joseph T. Hanlon and Jonathan Skinner (2012) “Sources of Regional Variation in Medicare Part D Drug Spending,” New England Journal of Medicine, 366(6):530–538.CrossrefWeb of ScienceGoogle Scholar

  • Doyle, Joseph J., John A. Graves, Jonathan Gruber and Samuel Kleiner (2012) “Do High-Cost Hospitals Deliver Better Care? Evidence from Ambulance Referral Patterns.” Working Paper 17936, National Bureau of Economic Research, Cambridge, MA.Google Scholar

  • Fisher, Elliott S., David D. Wennberg, Thrse A. Stukel, Daniel J. Gottlieb, F. L. Lucas and Étoile L. Pinder (2003a) “The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Wuality, and Accessibility of Care,” Annals of Internal Medicine, 138(4):273–287.CrossrefGoogle Scholar

  • Fisher, Elliott S., David D. Wennberg, Thrse A. Stukel, Daniel J. Gottlieb, F. L. Lucas and Étoile L. Pinder (2003b) “The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care,” Annals of Internal Medicine, 138(4):288–298.CrossrefGoogle Scholar

  • Gaynor, Martin, Jian Li and William B. Vogt (2007) “Substitution, Spending Offsets, and Prescription Drug Benefit Design,” Forum for Health Economics and Policy, 10(2): 1–31.Google Scholar

  • Gonzales, Ralph, Daniel C. Malone, Judith H. Maselli and Merle A. Sande (2001) “Excessive Antibiotic Use for Acute Respiratory Infections in the United States,” Clinical Infectious Diseases, 33(6):757–762.CrossrefGoogle Scholar

  • Green, Jonas B., Joseph S. Ross, Cynthia A. Jackevicius, Nilay D. Shah and Harlan M. Krumholz (2013) “When Choosing Statin Therapy: The Case for Generics,” JAMA Internal Medicine, 173(3):229–232.CrossrefPubMedWeb of ScienceGoogle Scholar

  • Institute of Medicine (2013) Variation in health care spending: Target decision making, not geography. In: (Joseph P. Newhouse, Alan M. Garber, Robin P. Graham, Margaret A. McCoy, Michelle Mancher, and Ashna Kibria, eds.) Washington, DC: The National Academies Press. Available at: http://www.iom.edu/Reports/2013/Variation-in-Health-Care-Spending-Target-Decision-Making-Not-Geography.aspx.

  • Ip, S., M. Chung, D. Moorthy, W. W. Yu, J. Lee, J. A. Chan, P. A. Bonis and J. Lau. (2011) Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease: Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep. (Comparative Effectiveness Reviews, No. 29.) Results.Google Scholar

  • MedPAC (2009) Report to the Congress: Measuring Regional Variation in Service Use. Washington, DC: Medicare Payment Advisory Commission. Available at: http://www.medpac.gov/documents/reports/Jan11_RegionalVariation_report.pdf.

  • Pope, Gregory C., John Kautter, Randall P. Ellis, Arlene S. Ash, John Z. Ayanian, Lisa I. Iezzoni, Melvin J. Ingber, Jesse M. Levy and John Robst (2004) “Risk Adjustment of Medicare Capitation Payments Using the CMS-HCC Model,” Health Care Financing Review, 25(4):119–141.PubMedGoogle Scholar

  • Roebuck, M. Christopher, Joshua N. Liberman, Marin Gemmill-Toyama and Troyen A. Brennan (2011) “Medication Adherence Leads to Lower Health Care Use and Costs Despite Increased Drug Spending,” Health Affairs, 30(1):91–99.CrossrefWeb of ScienceGoogle Scholar

  • Silber, Jeffery H., Robert Kaestner, Orit Even-Shoshan, Yanli Wang and Laura J. Bressler (2010) “Aggressive Treatment Style and Surgical Outcomes,” Health Services Research, 45(6 Part II):1872–1892.Web of ScienceCrossrefPubMedGoogle Scholar

  • Skinner, Jonathan S., Douglas O. Staiger and Elliott S. Fisher (2006) “Is Technological Change in Medicine Always Worth It? The Case of Acute Myocardial Infarction,” Health Affairs, 25(2):34–47.CrossrefGoogle Scholar

  • Steinman, Michael A., Katherine Y. Yang, Sepheen C. Byron, Judith H. Maselli and Ralph Gonzales (2009) “Variation in Outpatient Antibiotic Prescribing in the United States,” The American Journal of Managed Care, 15(12):861–868.PubMedGoogle Scholar

  • Wennberg, John E., Douglas O. Staiger, Sandra M. Sharp, Daniel J. Gottlieb, Gwyn Bevan, Klim McPherson and H. Gilbert Welch (2013) “Observational Intensity Bias Associated with Illness Adjustment: Cross Sectional Analysis of Insurance Claims,” British Medical Journal, 346(f549):1–11. Available at: http://www.bmj.com/content/346/bmj.f549.Web of Science

  • Zhang, Yuting, Katherine Baicker and Joseph P. Newhouse (2010) “Geographic Variation in Medicare Drug Spending,” New England Journal of Medicine, 363(5):405–409.CrossrefWeb of ScienceGoogle Scholar

  • Zhang, Yuting, Joseph P. Newhouse and Katherine Baicker (2011) “Are Drugs Substitutes or Complements for Intensive (and Expensive) Medical Treatment,” American Economic Review: Papers and Proceedings, 101(3):393–397.CrossrefGoogle Scholar

  • Zhang, Yuting, Seo Hyon Baik, A. Mark Fendrick and Katherine Baicker (2012a) “Comparing Local and Regional Variation in Health Care Spending,” The New England Journal of Medicine, 367(18):1724–1731.CrossrefGoogle Scholar

  • Zhang, Yuting, Michael A. Steinman and Cameron M. Kaplan (2012b) “Geographic Variation in Outpatient Antibiotic Prescribing Among Older Adults,” Archives of Internal Medicine, 172(19):1465–1471.Web of ScienceCrossrefGoogle Scholar

  • Zhang, Yuting, Shang-Hua Wu, A. Mark Fendrick and Katherine Baicker (2013) “Variation in Medication Adherence in Heart Failure,” JAMA Internal Medicine, 173(6):468–470.CrossrefWeb of SciencePubMedGoogle Scholar

About the article

Published Online: 2016-03-04

Published in Print: 2016-12-01


Citation Information: Forum for Health Economics and Policy, Volume 19, Issue 2, Pages 299–331, ISSN (Online) 1558-9544, ISSN (Print) 2194-6191, DOI: https://doi.org/10.1515/fhep-2015-0034.

Export Citation

©2016 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Laura M. Keohane, Robert J. Gambrel, Salama S. Freed, David Stevenson, and Melinda B. Buntin
Health Services Research, 2018

Comments (0)

Please log in or register to comment.
Log in